×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Sunshine Biopharma Inc. (SBFM) NASDAQ

$0.06 (0) (-0.18%)

Market Cap: $1.60M

As of 03/27/24 04:00 PM EDT. Market closed.

(SBFM)

Sunshine Biopharma Inc. (SBFM)
NASDAQ

$0.06
(0) (-0.18%)

Market Cap: $1.60M

As of 03/27/24 04:00 PM EDT. Market closed.

Add to Portfolio

sunshine biopharma inc (sbfm) is a pharmaceuticals company based out of 469 jean-talon west, 3rd floor, montreal, québec, ... read more

sunshine biopharma inc (sbfm) is a pharmaceuticals company based out of 469 jean-talon west, 3rd floor, montreal, québec, canada. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
2
URL
Address
.
PRICE CHART FOR SUNSHINE BIOPHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.06
Days Range
$0.06 - $0.06
52 week range
$0.04 - $1.40
Volume
1,850,782
Avg. Volume (30 days)
42,087,090
Market Cap
$1.60M
Dividend Yield
-
P/E
-
Shares Outstanding
28,024,290
Open
-
Previous Close
$0.06
Days Range
$0.06 - $0.06
52 week range
$0.04 - $1.40
Volume
1,850,782
Avg. Volume (30 days)
42,087,090
Market Cap
$1.60M
Dividend Yield
-
P/E
-
Shares Outstanding
28,024,290
FINANCIAL STATEMENTS FOR SUNSHINE BIOPHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SUNSHINE BIOPHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Slilaty Steve N.Chief Executive OfficerFeb 08, 2024 Buy$0.1020,0002,00030,000Feb 12, 2024, 04:05 PM
Sebaaly CamilleCFO/SecretaryNov 30, 2022 Buy$0.7630,00022,905174,465Dec 02, 2022, 06:01 AM
Sebaaly CamilleCFO/SecretaryJun 03, 2022 Buy$1.2225,00030,500144,465Jun 06, 2022, 12:36 PM
Slilaty Steve N.Chief Executive OfficerFeb 18, 2022 Option Exercise$0.10990,00099,00010,000Feb 22, 2022, 01:07 PM
MERZOUKI ABDERRAZZAKChief Operating OfficerJan 06, 2021 Option Exercise$0.0020,000,00020,00023,342,500Feb 16, 2021, 12:36 PM
Slilaty Steve N.Chief Executive OfficerJan 06, 2021 Option Exercise$0.0020,000,00020,00023,343,461Feb 16, 2021, 12:30 PM
Sebaaly CamilleCFO/SecretaryJan 06, 2021 Option Exercise$0.0020,000,00020,00023,893,086Feb 16, 2021, 12:23 PM
Sebaaly CamilleCFO/SecretaryDec 31, 2019 Option Exercise$0.00323,6733240Jul 15, 2020, 12:09 PM
Sebaaly CamilleCFO/SecretaryDec 19, 2019 Option Exercise$0.001,300,0001,3003,893,086Jul 15, 2020, 12:09 PM
Sebaaly CamilleCFO/SecretaryOct 20, 2019 Option Exercise$0.001,100,0001,1002,593,086Jul 15, 2020, 12:09 PM
Sebaaly CamilleCFO/SecretarySep 11, 2019 Option Exercise$0.00550,0005501,493,086Jul 15, 2020, 12:09 PM
MERZOUKI ABDERRAZZAKChief Operating OfficerDec 19, 2019 Option Exercise$0.001,300,0001,3003,342,500Jul 13, 2020, 02:39 PM
MERZOUKI ABDERRAZZAKChief Operating OfficerOct 20, 2019 Option Exercise$0.001,100,0001,1002,042,500Jul 13, 2020, 02:39 PM
Slilaty Steve N.Chief Executive OfficerDec 19, 2019 Option Exercise$0.001,300,0001,3003,343,461Jul 10, 2020, 01:26 PM
Slilaty Steve N.Chief Executive OfficerOct 20, 2019 Option Exercise$0.001,100,0001,1002,043,461Jul 10, 2020, 01:26 PM
Slilaty Steve N.Chief Executive OfficerDec 31, 2019 Option Exercise$0.00323,673324861,209Jul 10, 2020, 01:26 PM
Slilaty Steve N.Chief Executive OfficerJun 17, 2020 Option Exercise$0.10500,00050,0001,000,000Jun 25, 2020, 02:19 PM
MERZOUKI ABDERRAZZAKChief Operating OfficerSep 02, 2019 Option Exercise$0.0013,000,00013,00018,850,000Oct 07, 2019, 09:19 AM
MERZOUKI ABDERRAZZAKChief Operating OfficerAug 27, 2018 Option Exercise$0.0038,000,00038,000117,000,000Oct 07, 2019, 09:04 AM
MERZOUKI ABDERRAZZAKChief Operating OfficerJun 20, 2018 Option Exercise$0.0027,000,00027,00079,000,000Oct 07, 2019, 08:55 AM
MERZOUKI ABDERRAZZAKChief Operating OfficerJul 20, 2017 Option Exercise$0.0014,000,00014,00052,000,000Oct 04, 2019, 07:10 PM
MERZOUKI ABDERRAZZAKChief Operating OfficerDec 06, 2016 Option Exercise$0.0028,000,00028,00038,000,000Oct 04, 2019, 07:03 PM
MERZOUKI ABDERRAZZAKChief Operating OfficerApr 22, 2018 Option Exercise$0.0012,000,00012,00012,000,000Oct 04, 2019, 11:57 AM
Sebaaly CamilleSecretarySep 11, 2019 Option Exercise$0.0011,000,00011,00029,861,719Sep 23, 2019, 09:56 AM
Sebaaly CamilleSecretarySep 02, 2019 Option Exercise$0.0013,000,00013,00018,861,719Sep 23, 2019, 09:56 AM
Slilaty Steve N.Chief Executive OfficerSep 02, 2019 Option Exercise$0.0013,000,00013,00018,869,219Sep 23, 2019, 09:45 AM
MERZOUKI ABDERRAZZAKChief Operating OfficerAug 27, 2018 Option Exercise$0.0038,000,00038,000118,467,000Sep 14, 2018, 10:23 AM
Sebaaly CamilleSecretaryAug 27, 2018 Option Exercise$0.0038,000,00038,000117,234,373Sep 14, 2018, 10:14 AM
Slilaty Steve N.Chief Executive OfficerAug 27, 2018 Option Exercise$0.0038,000,00038,000117,384,373Sep 14, 2018, 10:08 AM
MERZOUKI ABDERRAZZAKChief Operating OfficerJun 20, 2018 Option Exercise$0.0027,000,00027,00080,467,000Jun 28, 2018, 05:57 PM
Sebaaly CamilleSecretaryJun 20, 2018 Option Exercise$0.0027,000,00027,00079,234,373Jun 28, 2018, 05:52 PM
Slilaty Steve N.Chief Executive OfficerJun 20, 2018 Option Exercise$0.0027,000,00027,00079,384,373Jun 28, 2018, 05:47 PM
MERZOUKI ABDERRAZZAKChief Operating OfficerJul 20, 2017 Option Exercise$0.0014,000,00014,00053,467,000Sep 08, 2017, 09:55 AM
Sebaaly CamilleSecretaryJul 20, 2017 Option Exercise$0.0014,000,00014,00052,234,373Sep 08, 2017, 09:45 AM
Slilaty Steve N.Chief Executive OfficerJul 20, 2017 Option Exercise$0.0014,000,00014,00052,384,373Sep 08, 2017, 09:28 AM
MERZOUKI ABDERRAZZAKChief Operating OfficerDec 06, 2016 Option Exercise$0.0026,000,00026,00039,467,000Dec 15, 2016, 07:58 PM
Sebaaly CamilleCFO and SecretaryDec 06, 2016 Option Exercise$0.0026,000,00026,00038,234,373Dec 15, 2016, 07:50 PM
Slilaty Steve N.Chief Executive OfficerDec 06, 2016 Option Exercise$0.0026,000,00026,00038,384,373Dec 15, 2016, 07:45 PM
Slilaty Steve N.Chief Executive OfficerJul 08, 2016 Option Exercise$0.00321,305,416835,394351,876,192Aug 01, 2016, 11:35 AM
Slilaty Steve N.Chief Executive OfficerApr 22, 2016 Option Exercise$0.0112,000,00084,00012,384,373Apr 26, 2016, 08:49 AM
Slilaty Steve N.Chief Executive OfficerApr 12, 2016 Buy$0.20253,08250,00930,570,776Apr 26, 2016, 08:49 AM
Sebaaly CamilleCFO and SecretaryApr 22, 2016 Option Exercise$0.0112,000,00084,00012,234,373Apr 25, 2016, 07:35 AM
MERZOUKI ABDERRAZZAKChief Operating OfficerApr 22, 2016 Option Exercise$0.0112,000,00084,00013,467,000Apr 25, 2016, 07:30 AM
Slilaty Steve N.Chief Executive OfficerMay 27, 2015 Buy$0.10500,00050,000500,000Jun 01, 2015, 08:26 PM
Slilaty Steve N.Chief Executive OfficerJan 09, 2015 Option Exercise$0.021,200,00024,00030,317,694Jan 22, 2015, 11:48 AM
Slilaty Steve N.Chief Executive OfficerJan 09, 2015 Option Exercise$0.02150,0003,000384,373Jan 22, 2015, 11:48 AM
Slilaty Steve N.Chief Executive OfficerSep 04, 2012 Option Exercise$0.052,591,500129,57531,517,694Oct 05, 2012, 08:50 PM
Slilaty Steve N.Chief Executive OfficerSep 04, 2012 Sale$0.052,591,500129,57531,517,694Sep 07, 2012, 08:00 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Slilaty Steve N.Chief Executive Officer02/08/20242,000
Sebaaly CamilleCFO/Secretary11/30/202222,905
Sebaaly CamilleCFO/Secretary06/03/202230,500
Slilaty Steve N.Chief Executive Officer02/18/202299,000
MERZOUKI ABDERRAZZAKChief Operating Officer01/06/202120,000
Slilaty Steve N.Chief Executive Officer01/06/202120,000
Sebaaly CamilleCFO/Secretary01/06/202120,000
Sebaaly CamilleCFO/Secretary12/31/2019324
Sebaaly CamilleCFO/Secretary12/19/20191,300
Sebaaly CamilleCFO/Secretary10/20/20191,100
Sebaaly CamilleCFO/Secretary09/11/2019550
MERZOUKI ABDERRAZZAKChief Operating Officer12/19/20191,300
MERZOUKI ABDERRAZZAKChief Operating Officer10/20/20191,100
Slilaty Steve N.Chief Executive Officer12/19/20191,300
Slilaty Steve N.Chief Executive Officer10/20/20191,100
Slilaty Steve N.Chief Executive Officer12/31/2019324
Slilaty Steve N.Chief Executive Officer06/17/202050,000
MERZOUKI ABDERRAZZAKChief Operating Officer09/02/201913,000
MERZOUKI ABDERRAZZAKChief Operating Officer08/27/201838,000
MERZOUKI ABDERRAZZAKChief Operating Officer06/20/201827,000
MERZOUKI ABDERRAZZAKChief Operating Officer07/20/201714,000
MERZOUKI ABDERRAZZAKChief Operating Officer12/06/201628,000
MERZOUKI ABDERRAZZAKChief Operating Officer04/22/201812,000
Sebaaly CamilleSecretary09/11/201911,000
Sebaaly CamilleSecretary09/02/201913,000
Slilaty Steve N.Chief Executive Officer09/02/201913,000
MERZOUKI ABDERRAZZAKChief Operating Officer08/27/201838,000
Sebaaly CamilleSecretary08/27/201838,000
Slilaty Steve N.Chief Executive Officer08/27/201838,000
MERZOUKI ABDERRAZZAKChief Operating Officer06/20/201827,000
Sebaaly CamilleSecretary06/20/201827,000
Slilaty Steve N.Chief Executive Officer06/20/201827,000
MERZOUKI ABDERRAZZAKChief Operating Officer07/20/201714,000
Sebaaly CamilleSecretary07/20/201714,000
Slilaty Steve N.Chief Executive Officer07/20/201714,000
MERZOUKI ABDERRAZZAKChief Operating Officer12/06/201626,000
Sebaaly CamilleCFO and Secretary12/06/201626,000
Slilaty Steve N.Chief Executive Officer12/06/201626,000
Slilaty Steve N.Chief Executive Officer07/08/2016835,394
Slilaty Steve N.Chief Executive Officer04/22/201684,000
Slilaty Steve N.Chief Executive Officer04/12/201650,009
Sebaaly CamilleCFO and Secretary04/22/201684,000
MERZOUKI ABDERRAZZAKChief Operating Officer04/22/201684,000
Slilaty Steve N.Chief Executive Officer05/27/201550,000
Slilaty Steve N.Chief Executive Officer01/09/201524,000
Slilaty Steve N.Chief Executive Officer01/09/20153,000
Slilaty Steve N.Chief Executive Officer09/04/2012129,575
Slilaty Steve N.Chief Executive Officer09/04/2012129,575
Load More Insider Transactions
FUNDS WITH A POSITION IN SUNSHINE BIOPHARMA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC66,6000.00003%NewOther
GEODE CAPITAL MANAGEMENT, LLC20,1790%No changeOther
CHANGE IN SHARES OUTSTANDING FOR SUNSHINE BIOPHARMA INC
STOCK BUYBACKS FOR SUNSHINE BIOPHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
1.34%
1Q
09/30/2023
03/31/2023
16.58%
2Q
09/30/2023
09/30/2022
36.03%
4Q
09/30/2023
06/30/2022
62.09%
5Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
1.34%
1Q
03/31/2023
16.58%
2Q
09/30/2022
36.03%
4Q
06/30/2022
62.09%
5Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SUNSHINE BIOPHARMA INC
LOADING...